Pharmaceuticals, Biotechnology and Life Sciences
Success demonstrates the power of EMMI, Terray’s proprietary AI platform integrated with its rapidly expanding 13B+ target-ligand binding database and…
DUBLIN–(BUSINESS WIRE)–The “Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: By Application Area, Type of Product Synthesized, Type…
Former Takeda CSO and a16z Bio + Health Founder to Guide Clinical Translation and Scaling of insitro’s ChemML™ Platform SOUTH…
Pharmacy-based plan expands hormone coverage, menopause-trained Care Guides and analytics to deliver a clinically proven approach to pharmacy benefits BETHESDA,…
Multi-year collaboration enables advanced diagnostic imaging and center of excellence in imaging sciences department across PET/CT, SPECT/CT, CT, MRI, and…
Served more than 35 years at Vetter, 23 years in the management Remains at the company in an advisory capacity…
Biomarker-activated cancer drug-candidate LP-184 demonstrates encouraging efficacy signals in DNA damage repair deficient tumors with an acceptable safety and tolerability…
Novel CD28 x Nectin-4 bispecific designed to overcome limitations of ADCs through durable and well-tolerated tumor-directed immune co-stimulation Milestone marks…
New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity…
SAN ANTONIO, Texas–(BUSINESS WIRE)–#ACS—bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other…